Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

EGFR K745_E746insIPVAIK

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

EGFR K745_E746insIPVAIK	Lung Cancer	EGFR K745_E746insIPVAIK	Lung Cancer	gefitinib Sensitive: C3 – Early Trials gefitinib Sensitive : C3	gefitinib Sensitive: C3 – Early Trials gefitinib Sensitive : C3
EGFR K745_E746insIPVAIK	Lung Cancer	EGFR K745_E746insIPVAIK	Lung Cancer	icotinib Sensitive: C3 – Early Trials icotinib Sensitive : C3	icotinib Sensitive: C3 – Early Trials icotinib Sensitive : C3
EGFR K745_E746insIPVAIK	Lung Cancer	EGFR K745_E746insIPVAIK	Lung Cancer	erlotinib Sensitive: C3 – Early Trials erlotinib Sensitive : C3	erlotinib Sensitive: C3 – Early Trials erlotinib Sensitive : C3
EGFR K745_E746insIPVAIK	Lung Cancer	EGFR K745_E746insIPVAIK	Lung Cancer	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3
EGFR K745_E746insIPVAIK	Lung Cancer	EGFR K745_E746insIPVAIK	Lung Cancer	osimertinib Sensitive: C3 – Early Trials osimertinib Sensitive : C3	osimertinib Sensitive: C3 – Early Trials osimertinib Sensitive : C3